- n
- 12 (11 analyzed)
- Design
- RCT crossover
- Dose
- 125 mL
- Window
- 60 s
Randomized, double-blind, placebo-controlled crossover
Progress in Medicine 2020;40:547–5491
- Result
- Capillary blood-flow velocity higher than placebo at 30 and 60 seconds. SpO₂ no different from placebo.
- Limits
- Small sample, one-minute window, company-affiliated authors.








